
--- Page 1 ---
Cucar Case Repore (For Coilection of Cancerous Tissue) Informed Consent I personally informed this natient that a specimen(s) would be' collected to be used for research purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Clinical Information GENERALINFORMATIONSAS Marita! Status Race Temperature Gender Weight Blood Pressure Heart Rate  S HISTORY OF PRESENT ILLNESS Symptoms: Wss W ei oy Clinical Findings: Performance Scale (Karnofsky Score):  100 Asymptomatic  80-90 Symptomatic but Fully Ambulatory  60-70 Symptomatic, in bed less than 50% of day.  40-50 Symptomatic, in bed more than 50% of day, but not bed ridden.   20-30 Bed Ridden SCURRENT MEDICATIONS EDSSRAS Drug Dose Route Frequency Date (mm/dd/yyyy) To To / To / / To / To

--- Page 2 ---
SAPASTMEDICAL HISTORY Diagnosis/Disease/Disorder/Injury Diagnosis Date Treatment Status SOCIALHISTORY Occupation:  Environmental Hazards: Smoking History. Current Status TYPE  Packs/day Duration When Quit  YES *NO (yrs) (y) Alcohol Consumption Current Status TYPE Drinks/day Duration When Quit YES NO (yrs) (yr) Drug Use Current Status TYPE Frequency Duration When Quit  YES tPNO (yrs) (yr) SSFAMILYMEDICALHISTORYPSS Relative Diagnosis Age of Diagnosis. LABDATA Test Result Date Test Result Date HIV  Positive: CEA  Negative  Positive: Negative Hep B Negative  Positive: CA 15-3   Negative  Positive: CA 19-9   Negative  Positive: Hep C  Negative  Positive: AFP PSA  Positive:   Negative  Positive:   Negative Other: Other:   Positive:  Negative  Positive:  Negative B/T Cell Markers: 2

--- Page 3 ---
Study Results Date Ultrasound X-Ray CT MRI  Biopsy CLINICALDIAGNOSIS Preoperative Clinical Diagnosis Location of Suspected Involved Lymph Nodes Location of Suspected Distant Metastasis Clinical Staging Date of Diaanosis t3 no mo Stage: Treatment Information ESSSURGICAL TREATMENTEESA Procedure Date of Procedure 7 Primary Tumor Organ Detailed Location Size x x cm Extension of Tumor Lymph Nodes Location of Lymph Nodes # of Lymph Nodes Description Palpable, Non-Dissected Lymph Nodes Dissected Lymph Nodes Distant Metastasis Organ Detailed Location Size Surgical Staging No. mo Stage:7 NEOADJUVENT THERAPY ChemoRadiation Immuno Hormonal or Molecular  Date (mm/dd/yyyy) Drug/Treatment Dose Route Frequency To / To ! To / To / / To / 3

--- Page 4 ---
Pathology Form Specimen Information Collected by: Dat Time Preserved by:a Da Time SPECIMEN TYPE #of samples provided)  Frozen Paraffin Block  Blood/Serum/Plasma Slide Diseased Normal Diseased  Normal Diseased Normal Diseased  Normal 2 2 Z Time to LN2 Time to Formalin Time to LN2 A min min min PATHOLOGICALDESCRIPTION Primary Tumor Organ Size Extension of Tumor Distance to NAT C lom teman c x 3 x 2 cmASCeu dzcjq 6 cm Lymph Nodes Location # Examined # Metastasized Distant Metastasis Organ Detailed Location Size Pathological Staging pT 3 Na M o Stage: Notes:

--- Page 5 ---
Microscopic Description  Histological Patterne a Cell Distribution + Structural Pattern + Diffuse  Streaming  Mosaic  Storiform  Necrosis Fibrosis  Lymphocytic Infiltration  Palisading  Vascular Invasion  Cystic Degeneration  Clusterized  Bleeding  Alveolar Formation  Myxoid Change  Indian File  Psammoma/Calcification Cellular Differentiation Squamous + Adenomatous + Sarcomatous + Lymphomatous  Squamoid Cell Glandular cell  Round Cell Large Cell Spindle Cell Cell Stratification Fibroblast Small Cell  Keratin Secretion Osteoblast  RS Cell/RS Like Desmosome Intracyt. Vacuole  Lipoblast Inflam. Cell  Pearl  Gland formation Myoblast  Plasma Cell Cellular Differentiation: Well Moderate Poor Nuclear Atypia: 0 1 II III Aniso Nucleosis Hyperchromatism  Nucleolar Prominent Multinucleated Giant Cell  Mitotic Activity Nuclear Grade:  Marker  Result Value Date ER  Negative  Positive PR  Negative   Positive Her-2/neu  Negative  Positive B-Cell Marker  Negative  Positive T-Cell Marker  Negative  Positive Other:  Negative  Positive Other:  Negative  Positive Final Pathology Report 0c/enocorcj`sima o1 tR Coln Histological Diagnosis: Meeetqtohe olilekeoritaied Grade: Comments: Pathologist 5

--- Page 6 ---
CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM* Microscopic Appearance: Histological pattern: CELL DISTRIBUTION Diffuse + STRUCTURAL PATTERN X Streaming Mosaic Storiform Necrosis Fibrosis Lymphocytic Infiltration x  Palisading  Vascular Invasion X Cystic Degeneration Clusterized Bleeding... Alveolar Formation XI  Myxoid Change Indian File Psammoma/Calcification 2. Cellular features:  Squamous +. Adenomatous +  Sarcomatous + Lymphomatous  Squamoid Cell Glandular cell Round Cell  Large Cell Spindle Cell  Cell Stratification X Fibroblast Small Cel!  Keratin Secretion V Osteoblast RS CeIl/RS Like  Desmosome Intracyt. Vacuole  Lipoblast  Inflam. Cell Pear!  Gland formation Myoblast Plasma Cell Otherwise Specified: D( (0)e Drs0% S. : 5OZ D4 s0Z - NQ0QAos 2. Cellular Differentiation: Well Moderately  Poor X 3. Nuclear Atypia: Nuclear Appearance I1  Aniso Nucleosis Hyperchromatism Nucleolar Prominent Multinucleated Giant Cell Mitotic Activity X Nuclear Grade Ao(esocesergog 4) Histological Diagnosis: Comments Date ATHOLOGIST STAFF FOR RESEARCH USE ONLY). *(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AND